These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34608018)

  • 1. ACUTE MACULAR NEURORETINOPATHY AFTER COVID-19 VACCINATION.
    Zaheer N; Renju MP; Chavan R
    Retin Cases Brief Rep; 2022 Jan; 16(1):9-11. PubMed ID: 34608018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACUTE MACULAR NEURORETINOPATHY AFTER SARS-COV-2 VACCINATION.
    Patel SN; Yonekawa Y
    Retin Cases Brief Rep; 2022 Jan; 16(1):5-8. PubMed ID: 34608019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination.
    Menteş J; Nalçacı S; Değirmenci C
    Turk J Ophthalmol; 2023 Jun; 53(3):186-191. PubMed ID: 37345327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination.
    Mambretti M; Huemer J; Torregrossa G; Ullrich M; Findl O; Casalino G
    Ocul Immunol Inflamm; 2021 May; 29(4):730-733. PubMed ID: 34187278
    [No Abstract]   [Full Text] [Related]  

  • 5. Bilateral Acute Macular Neuroretinopathy after COVID-19 Vaccination and Infection.
    Bellur S; Zeleny A; Patronas M; Jiramongkolchai K; Kodati S
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1222-1225. PubMed ID: 35914286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACUTE MACULAR NEURORETINOPATHY FOLLOWING SARS-CoV-2 VACCINATION.
    Afonso MG; Marques JH; Monteiro S; Lume M; Abreu AC; Maia S
    Retin Cases Brief Rep; 2023 Jul; 17(4):438-440. PubMed ID: 37364205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Cases of Acute Macular Neuroretinopathy Associated with the Adenovirus-based COVID-19 Vaccine Vaxzevria (Astrazeneca).
    Franchi A; Rauchegger T; Palme C; Frede K; Haas G; Blatsios G; Kralinger M; Zehetner C
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1234-1239. PubMed ID: 35050829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination.
    Vinzamuri S; Pradeep TG; Kotian R
    Indian J Ophthalmol; 2021 Oct; 69(10):2862-2864. PubMed ID: 34571652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal Imaging in Acute Macular Neuroretinopathy.
    Botsford BW; Kukkar P; Bonhomme G
    J Neuroophthalmol; 2021 Sep; 41(3):e357-e359. PubMed ID: 33136676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracentral Acute Middle Maculopathy.
    Kıyat P; Değirmenci C; Nalçacı S; Afrashi F; Akkın C
    Turk J Ophthalmol; 2020 Jun; 50(3):193-196. PubMed ID: 32631028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of acute macular neuroretinopathy following COVID-19 infection.
    Feng H; Zhao M; Mo J; Cao X; Chen W; Wang H
    BMC Ophthalmol; 2024 Jan; 24(1):19. PubMed ID: 38200478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Acute Macular Neuroretinopathy or Paracentral Acute Middle Maculopathy with Sickle Cell Disease.
    Ong SS; Ahmed I; Scott AW
    Ophthalmol Retina; 2021 Nov; 5(11):1146-1155. PubMed ID: 33476854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral Sequential Acute Macular Neuroretinopathy in an Asian Indian Female with β Thalassemia Trait following (Corona Virus Disease) COVID-19 Vaccination and Probable Recent COVID Infection - Multimodal Imaging Study.
    Sanjay S; Gadde SGK; Kumar Yadav N; Kawali A; Gupta A; Shetty R; Mahendradas P
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1222-1227. PubMed ID: 35050826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Imaging Characteristics and Functional Test Findings in a Case of Acute Macular Neuroretinopathy Accompanied by Behçet Disease.
    Batıoğlu F; Yanık Ö; Demirel S; Özmert E
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1424-1430. PubMed ID: 32510267
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford-AstraZeneca COVID-19 vaccine.
    Gabrielle PH; Baudin F; Ben Ghezala I; Meillon C; Bron AM; Arnould L; Creuzot-Garcher C
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101281. PubMed ID: 35075438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review.
    Fekri S; Khorshidifar M; Dehghani MS; Nouri H; Abtahi SH
    J Fr Ophtalmol; 2023 Jan; 46(1):72-82. PubMed ID: 36496293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Macular Neuroretinopathy Following COVID-19 mRNA Vaccination.
    Rennie AT; DeWeerd AJ; Martinez MG; Kay CN
    Cureus; 2022 Jul; 14(7):e27502. PubMed ID: 36060339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute macular neuroretinopathy in a patient with acute coronary syndrome.
    Agarwal P; Kumar V; Singh P; Banerjee M
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute macular neuroretinopathy associated with COVID-19 infection.
    David JA; Fivgas GD
    Am J Ophthalmol Case Rep; 2021 Dec; 24():101232. PubMed ID: 34778601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Morphological Characteristics of Anti-Programmed Death Ligand 1-Associated Retinopathy: Expanding the Spectrum of Acute Macular Neuroretinopathy.
    Ramtohul P; Freund KB
    Ophthalmol Retina; 2020 Apr; 4(4):446-450. PubMed ID: 31926948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.